Ming-Tsung Hsu Selected Research

1- benzyl- 2- (5- methyl- 2- furyl)benzimidazole

1/2016

A novel thromboxane receptor antagonist, nstpbp5185, inhibits platelet aggregation and thrombus formation in animal models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ming-Tsung Hsu Research Topics

Disease

1	Neoplasms (Cancer) 01/2022
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Hemorrhage 01/2016
1	Pulmonary Embolism 01/2016
1	Thrombosis (Thrombus) 01/2016
1	Hyperparathyroidism 08/2008
1	Hoarseness 08/2008
1	Hyperphosphatemia 08/2008
1	Tissue Adhesions 08/2008
1	Chronic Kidney Failure (Chronic Renal Failure) 08/2008
1	Inflammation (Inflammations) 08/2008
1	Hypocalcemia 08/2008

Drug/Important Bio-Agent (IBA)

2	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2008
1	LipidsIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	1- benzyl- 2- (5- methyl- 2- furyl)benzimidazoleIBA 01/2016
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2016
1	Thromboxane Receptors (Thromboxane Receptor)IBA 01/2016
1	Ethanol (Ethyl Alcohol)IBA 08/2008

Therapy/Procedure

2	Therapeutics 01/2022 - 08/2008
1	Parathyroidectomy 08/2008